Wockhardt Bio Ag
1 products tracked · names used in filings: Wockhardt Bio Ag
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 29 May 2026🇺🇸 FDA approval
FDA approves Zaynich (cefepime hydrochloride, zidebactam), a new medicine
Wockhardt Bio Ag; NDA220787; New molecular entity, Priority review; powder · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Zaynich cefepime hydrochloride, zidebactam | Approved | 2026-05-29 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.